Sunshine Biopharma Inc. entered into a Release Agreement with Malek Chamoun, the former president of Nora Pharma Inc., a wholly-owned subsidiary, on July 8, 2026, to settle a dispute. The company agreed to pay CAD$1,500,000 (approximately US$1,058,565) in full and final settlement. Sunshine Biopharma Inc. operates in the biopharma industry and develops products for ocular-related diseases.
